Association of Symptoms and Viral Culture Positivity for SARS‐CoV‐2—Tennessee, April–July 2020

Author:

Biddle Jessica E.1ORCID,Bonenfant Gaston1,Grijalva Carlos G.23,Zhu Yuwei4,Halasa Natasha B.5,Chappell James D.5,Mellis Alexandra1ORCID,Reed Carrie1,Talbot H. Keipp26,Zhou Bin1,Rolfes Melissa A.1ORCID

Affiliation:

1. Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA

2. Department of Health Policy Vanderbilt University Medical Center Nashville Tennessee USA

3. Department of Biomedical Informatics Vanderbilt University Medical Center Nashville Tennessee USA

4. Department of Biostatistics Vanderbilt University Medical Center Nashville Tennessee USA

5. Department of Pediatrics Vanderbilt University Medical Center Nashville Tennessee USA

6. Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

Abstract

ABSTRACTBackgroundUnderstanding how symptoms are associated with SARS‐CoV‐2 culture positivity is important for isolation and transmission control guidelines.MethodsIndividuals acutely infected with SARS‐CoV‐2 in Tennessee and their household contacts were recruited into a prospective study. All participants self‐collected nasal swabs daily for 14 days and completed symptom diaries from the day of illness onset through day 14 postenrollment. Nasal specimens were tested for SARS‐CoV‐2 using RT‐qPCR. Positive specimens with cycle threshold values < 40 were sent to the Centers for Disease Control and Prevention (CDC) for viral culture. First, we modeled the association between symptoms and the risk of culture positivity using an age‐adjusted generalized additive model (GAM) accounting for repeated measurements within participants and a symptom‐day spline. Next, we investigated how timing of symptom resolution was associated with the timing of culture resolution.ResultsIn a GAM restricted to follow‐up days after symptoms began, the odds of a specimen being culture positive was significantly increased on days when wheezing, loss of taste or smell, runny nose, nasal congestion, sore throat, fever, or any symptom were reported. For all symptoms except sore throat, it was more common for participants to have culture resolution before symptom resolution than for culture to resolve after or on the same day as symptom resolution.ConclusionsOverall, symptomatic individuals were more likely to be SARS‐CoV‐2 viral culture positive. For most symptoms, culture positivity was more likely to end before symptoms resolved. However, a proportion of individuals remained culture positive after symptom resolved, across all symptoms.

Funder

Centers for Disease Control and Prevention

National Center for Advancing Translational Sciences

Publisher

Wiley

Reference15 articles.

1. “Symptoms of COVID‐19 ” (2023) 2022 [cited 2023 January 25] https://www.cdc.gov/coronavirus/2019‐ncov/symptoms‐testing/symptoms.html.

2. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020

3. “Isolation and Precautions for People With COVID‐19 ” (2023) 2023 [cited 2023 August 30] https://www.cdc.gov/coronavirus/2019‐ncov/your‐health/isolation.html.

4. Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020–2022

5. Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3